UNITED HEALTH PRODUCTS, INC. (OTCMKTS:UEEC) Files An 8-K Regulation FD DisclosureItem 7.01. Regulation FD Disclosure
On December 4, 2017, the Company issued a press release, a copy of which is appended hereto.
Item 9.01. Financial Statements and Exhibits.
United Health Products, Inc. ExhibitEX-99.1 2 ueec_ex991.htm PRESS RELEASE ueec_ex991.htmEXHIBIT 99.1 FDA Selects HemoStyp® for CtQ Pilot Program Henderson,…To view the full exhibit click here
About UNITED HEALTH PRODUCTS, INC. (OTCMKTS:UEEC)
United Health Products, Inc. is a product development and solutions company. The Company develops, manufactures and markets hemostatic gauze for the healthcare and wound care sectors. The Company’s product, HemoStyp, is derived from regenerated oxidized cellulose and designed to absorb exudate/drainage from wounds and to help control bleeding. The Company is focused on identifying new markets and applications for its product. The Company has received orders from the dental and medical markets and is pursuing various markets for HemoStyp, including the medical, sports and veterinary sectors. Its HemoStyp Hemostatic Gauze is a hemostatic agent that controls bleeding from open wounds and body cavities. Its hemostatic gauze product line includes various configurations. Its hemostatic gauze product line includes dental gauze for oral surgery, approximately four versions of Trauma Gauze for battlefield trauma and approximately two island dressings to support intravenous procedures.